Vx-006
/ Vaxon Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 19, 2019
Safety Study of Vx006 Vaccine in Solid Tumor Patients
(clinicaltrials.gov)
- P1; N=23; Completed; Sponsor: Vaxon Biotech; Active, not recruiting ➔ Completed
Clinical • Trial completion
1 to 1
Of
1
Go to page
1